Assessing HER2 status in breast cancer through next-generation sequencing of circulating tumor cells.
Overview
publication date
- April 22, 2024
published in
Research
keywords
- Breast Neoplasms
- High-Throughput Nucleotide Sequencing
- Neoplastic Cells, Circulating
- Receptor, ErbB-2
Identity
Digital Object Identifier (DOI)
- 10.1177/03936155241246542
PubMed ID
- 38646675